Semax vs Selank: Cognitive vs Anxiolytic Peptide

Semax vs Selank: Cognitive vs Anxiolytic Peptide Comparison

Semax is a synthetic heptapeptide derived from ACTH(4-10) that enhances cognition, focus, and memory through BDNF upregulation and dopaminergic modulation. It is approved in Russia for stroke recovery and cognitive disorders. Selank is a synthetic heptapeptide derived from the immunopeptide tuftsin that provides anxiolytic and immunomodulatory effects through GABAergic enhancement and enkephalinase inhibition. Both were developed at the Russian Institute of Molecular Genetics, share intranasal administration, and feature the stabilizing Pro-Gly-Pro C-terminal extension, but target different neurological pathways.

Side-by-Side Comparison

Mechanism

BDNF upregulation; dopamine/serotonin modulation; neuroprotection

GABAergic enhancement; enkephalinase inhibition; cytokine regulation

Evidence Grade

B+

B

Derived From

ACTH(4-10) + Pro-Gly-Pro

Tuftsin + Pro-Gly-Pro

Primary Effect

Cognitive enhancement, focus, neuroprotection

Anxiolytic, immune modulation, stress reduction

Route

Intranasal (primary); subcutaneous

Typical Dose

200 - 600 mcg/day intranasal

250 - 500 mcg/day intranasal

Half-Life

~2-3 minutes (plasma); effects last hours

Best For

Focus, memory, stroke recovery, ADHD research

Anxiety, stress, immune support, GAD research

FDA Status

Not FDA-approved; approved in Russia

Cost (research grade)

$$

Semax: Pros & Cons

Advantages

Potent BDNF upregulation (neuroprotective)

Enhances focus, attention, and memory

Approved in Russia for stroke and cognitive disorders

Non-invasive intranasal administration

No reported dependence or withdrawal

Neuroprotective against ischemic damage

Considerations

Most clinical data in Russian-language literature

Very short plasma half-life (minutes)

Not FDA-approved in Western countries

May cause irritability in sensitive individuals

Limited Western clinical trial data

Selank: Pros & Cons

Anxiolytic without sedation or dependence

Dual anxiolytic + immunomodulatory effects

Non-invasive intranasal delivery

No benzodiazepine-like side effects

Enhances enkephalin levels naturally

Approved in Russia for anxiety disorders

Weaker cognitive enhancement than semax

Most clinical data in Russian literature

Not FDA-approved

Short plasma half-life

Limited availability outside research suppliers

Less studied than benzodiazepines for anxiety

Which Is Right for Your Research?

Decision Guide

Choose semax if: Your research targets cognitive enhancement, focus improvement, BDNF-mediated neuroprotection, stroke recovery, or ADHD-related mechanisms. Semax's dopaminergic and BDNF-modulating properties make it the stronger nootropic for pure cognitive performance research.

Choose selank if: Your research targets anxiety reduction without sedation, stress resilience, immune modulation, or generalized anxiety disorder mechanisms. Selank's GABAergic and enkephalinase-inhibiting properties provide anxiolytic effects without the dependence or cognitive impairment associated with benzodiazepines.

Stack both if: Your research requires both cognitive enhancement and anxiety reduction. The semax + selank stack is the most popular nootropic peptide combination, with semax providing focus/BDNF upregulation and selank providing calm/anxiety reduction. A common protocol uses semax in the morning and selank in the afternoon.

Frequently Asked Questions

Semax is generally more effective for focus and cognitive enhancement. Its ACTH-derived mechanism upregulates BDNF and modulates dopamine/serotonin for attention and memory. Selank can indirectly improve focus by reducing anxiety, but its primary target is GABA-mediated anxiolysis.

Yes, they are commonly stacked as complementary nootropic peptides. Semax for focus/BDNF and selank for anxiety reduction/immune support. Both use intranasal delivery, making combined protocols practical. A typical approach uses semax in the morning and selank later in the day.

Semax derives from ACTH(4-10) targeting cognition through BDNF and dopaminergic pathways. Selank derives from tuftsin targeting anxiety through GABAergic enhancement and enkephalinase inhibition. Both were developed at the same Russian institute and share the Pro-Gly-Pro stability modification.

Related Protocol Guides

Compare More

Verified Research Suppliers

★ LiveWell Peptides — Preferred Vendor • cGMP Certified Preferred vendor

Core Peptides — Third-party tested

— Broad catalog

Biotech Peptides — USA-based

Related Resources